PXD068731 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Immunopeptidomics of Acute Myeloid Leukemia (AML) Blast cells after Therapy-Induced Senescence (TIS) with Cytarabine. |
| Description | Resistance or relapse upon chemotherapy are major determinants of treatment failure in acute myeloid leukemia (AML). Therapy-induced senescence (TIS) is a potential outcome of chemotherapy, but its immunological consequences in AML remain unclear. We show that ex-vivo chemotherapy induces senescence in a subset of therapy-naïve AML samples. TIS is marked by elevated interferon signaling, upregulation of HLA class I/II molecules, and increased presentation of leukemia and senescence-associated peptides, conferring AML blasts antigen-presenting cell-like features. Patient-derived leukemic blasts purified from AML samples were either treated with cytarabine (AraC) or left untreated. Further, samples that exhibited a significant increase in fluorescent SA-β-Gal upon treatment were classified as Senescence High (Sen High), whereas others that showed minimal change were classified as Senescence Low (Sen Low). We employed our in-house microfluidic platform, PeptiCHIP for immunoaffinity purification followed by Ligandomics LC/MS analysis, to identify HLA class I-bound peptides in Patient-derived leukemic blasts, seeking to compare the immunopeptidome repertoire of Sen Low and Sen High samples before and after cytarabine treatment. Sen High exhibited a greater number of eluted peptides compared to Sen Low samples already at baseline. This number was further increased following chemotherapy in all Sen High samples analyzed. Conversely, the number of peptides retrieved in Sen Low samples remained low regardless of chemotherapy treatment. |
| HostingRepository | PRIDE |
| AnnounceDate | 2026-08-20 |
| AnnouncementXML | Submission_2026-08-19_22:38:29.059.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Rui Branca |
| SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606; |
| ModificationList | monohydroxylated residue |
| Instrument | timsTOF SCP |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2025-09-23 03:04:44 | ID requested | |
| ⏵ 1 | 2026-08-19 22:38:29 | announced | |
Publication List
| Dataset with its publication pending |
Keyword List
| submitter keyword: Immunopeptidomics, Therapy-Induced Senescence, TIS, HLA, Ligandome, MHC, cytarabine, Ligandomics, Immunopeptidome, TimsTOF SCP, Acute Myeloid Leukemia, AML |
Contact List
| Janne Lehtiö |
| contact affiliation | Dept. Oncology-Pathology, Scilifelab, Karolinska Institutet, Sweden |
| contact email | janne.lehtio@ki.se |
| lab head | |
| Rui Branca |
| contact affiliation | Clinical Proteomics Unit, Dep. of Oncology-Pathology |
| contact email | rui.mamede-branca@ki.se |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/08/PXD068731 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD068731
- Label: PRIDE project
- Name: Immunopeptidomics of Acute Myeloid Leukemia (AML) Blast cells after Therapy-Induced Senescence (TIS) with Cytarabine.